Ameera Patel, CEO at TidalSense: TidalSense diagnoses lung disease in under 4 minutes

TidalSense has built a handheld device that diagnoses COPD, a common lung disease, in under four minutes. It's already used across the NHS and has drawn interest from more than 60 countries since launching last year. The Cambridge-based company just raised $19m to expand into new markets.Ameera Patel is CEO of TidalSense. She believes what matters most to healthcare providers is a better patient experience and more efficient care.The Scaling Europe show is presented by Deel. Check them out here: https://get.deel.com/ruynb7o4lfjkSponsors:Chargebee: https://www.chargebee.com/events/beelieve/london/2026SurrealDB: https://surrealdb.com/Airwallex: https://www.airwallex.com/uk?utm_source=other&utm_medium=partner_referral&utm_campaign=v01_emea_multi_ib_dg_prtmk_mofu_scalingeuropeLovable: https://lovable.dev/Timestamps:0:00 - Introduction0:19 - TidalSense's $19m round and what problem it solves1:08 - Why the standard diagnostic test hasn't changed since the 1800s2:44 - What TidalSense has built3:35 - TidalSense's rollout across the NHS4:21 - The demand TidalSense has seen since launching5:16 - Ameera's personal journey to founding TidalSense9:48 - Inside TidalSense's $19m round and its lead investor12:02 - TidalSense's plans to expand into the US and China14:47 - TidalSense's biggest bottleneck right now15:59 - What's needed for TidalSense's next raise